www.fdanews.com/articles/143055-fda-grants-orphan-status-to-hcmv-drug
FDA Grants Orphan Status to HCMV Drug
January 9, 2012
The FDA has granted orphan drug status to the novel human cytomegalovirus (HCMV) inhibitor AIC246 (Letermovir) for the prevention of HCMV-related viremia and disease in at-risk patients.
MedPage Today
MedPage Today